Infectious diseases in Iran: A bird's eye view

Clinical Microbiology and Infection

Volumn 18, Issue 11, 2012, Pages 1081-1088

  Askarian, M ^a   Mansour Ghanaie, R ^b   Karimi, A ^b   Habibzadeh, F ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NATIONAL IRANIAN OIL COMPANY   (Iran)

Author keywords

Bacterial infections; Communicable diseases; Drug resistance; Epidemiology; Incidence; Infection control; Microbial; Parasitic diseases; Prevalence; Viral diseases

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CARBAPENEM; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; HEPATITIS B VACCINE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BRUCELLOSIS; CHLAMYDIASIS; CRIMEAN CONGO HEMORRHAGIC FEVER; DRACUNCULIASIS; ECHINOCOCCOSIS; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; FASCIOLIASIS; GOOD CLINICAL PRACTICE; HEALTH CARE SYSTEM; HEALTH EDUCATION; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INFECTION; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; IRAN; LEPTOSPIROSIS; LISTERIOSIS; MALARIA; NONHUMAN; PARASITOSIS; PREVALENCE; PRIORITY JOURNAL; Q FEVER; REVIEW; SANITATION; SCHISTOSOMIASIS; SKIN LEISHMANIASIS; TUBERCULOSIS; VACCINATION; VIRUS HEPATITIS; VIRUS INFECTION;

AVES; BACTERIA (MICROORGANISMS); HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84867694967     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12021     Document Type: Review

References (100)

1. World Health Organization. The world health report-50 facts: global health situation and trends 1955-2025.Available at: Http://www.Who.Int/whr/1998/media_centre/50facts/en/ (last accessed 23 June 2012).
2. Khosravi A, Taylor R, Naghavi M, Lopez AD. Mortality in the Islamic Republic of Iran, 1964-2004. Bull World Health Organ 2007; 85: 607-614.
3. Habibzadeh F. The control of non-communicable diseases in rural Iran. Lancet 2012; 379: 6-7.
4. Merat S, Rezvan H, Nouraie M et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med 2010; 13: 99-104.
5. Malekzadeh R, Riyahi A. Viral hepatitis. In: Azizi F, Janghorbani M, Hatami H, eds. Epidemiology and control of common disease in Iran, 3rd edn. Tehran: Shahid Beheshti University of Medical Sciences, 2010; 853-886. [In Persian.]
6. Ramezani H, Bozorgi SH, Nooranipour M et al. Prevalence and risk factors of hepatitis A among blood donors in Qazvin, central Iran. Singapore Med J 2011; 52: 107-112.
7. Sofian M, Aghakhani A, Farazi AA et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis 2010; 8: 176-179.
8. Alian S, Ajami A, Ghasemian R, Yadegarinia D. Age-specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran. East Mediterr Health J 2011; 17: 754-758.
9. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointest Liver Dis 2007; 16: 403-406.
10. Alavian SM, Hajarizadeh B, Ahmadzad-AAsl M, Kabir A. Hepatitis B virus infection in Iran: a systematic review. Hepat Mon 2008; 8: 281-294.
11. Alavian SM, Keyvani H, Rezai M, Ashayeri N, Sadeghi HM. Preliminary report of hepatitis B virus genotype prevalence in Iran. World J Gastroenterol 2006; 12: 5211-5213.
12. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A et al. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol 2005; 76: 318-326.
13. Alizadeh AH, Ranjbar M, Ansari S et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J 2006; 12: 528-537.
14. Askarian M, Yadollahi M, Kuochak F, Danaei M, Vakili V, Momeni M. Precautions for health care workers to avoid hepatitis B and C virus infection. Int J Occup Environ Med 2011; 2: 191-198.
15. Jahani MR, Motevalian SA, Mahmoodi M. Hepatitis B carriers in large vehicle drivers of Iran. Vaccine 2003; 21: 1948-1951.
16. Askarian M, Khalooee A, Emroodi NN. Personal hygiene and safety of governmental hospital staff in Shiraz, Islamic Republic of Iran. East Mediterr Health J 2006; 12: 768-774.
17. Hosseini Asl SK, Avijgan M, Mohamadnejad M. High prevalence of HBV, HCV, and HIV infections in gypsy population residing in Shahr-e-kord. Arch Iran Med 2004; 7: 20-22.
18. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25 (suppl 1): 3-8.
19. Fallahian F, Najafi A. Epidemiology of hepatitis C in the Middle East. Saudi J Kidney Dis Transpl 2011; 22: 1-9.
20. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med 2007; 17: 425-433.
21. Alavian SM, Tabatabaei SV, Lankarani KB. Epidemiology of HCV infection among thalassemia patients in eastern Mediterranean countries: a quantitative review of literature. Iran Red Crescent Med J 2010; 12: 365-376.
22. Habibzadeh F, Haghshenas M. Hepatitis C. Iran J Med Sci 1996; 21: 1-2.
23. Habibzadeh F. Thalassaemia in the Middle East. Lancet ME 2012. Available at: Http://download.Thelancet.Com/flatcontentassets/pdfs/mar12_middleeasted_transplantation.Pdf?Elsca1=050312&elsca2=middleeadted&elsca3=segment (last accessed 23 June 2012).
24. Alavian SM, Aalaei-Andabili SH. Lack of knowledge about hepatitis C infection rates among patients with inherited coagulation disorders in countries under the Eastern Mediterranean Region Office of WHO (EMRO): a meta-analysis. Hepat Mon 2012; 12: 244-252.
25. Alavian SM, Tabatabaei SV, Mahboobi N. Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literature. J Public Health 2011; 19: 191-203.
26. Broumand B, Hakemi MS, Sabet MS. Impact of hepatitis C virus infection on short-term outcomes in renal transplantation. Exp Clin Transplant 2004; 2: 242-245.
27. Mohtasham Amiri Z, Rezvani M, Jafari Shakib R, Jafari Shakib A. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. East Mediterr Health J 2007; 13: 250-256.
28. Day C, Nassirimanesh B, Shakeshaft A, Dolan K. Patterns of drug use among a sample of drug users and injecting drug users attending a general practice in Iran. Harm Reduct J 2006; 3: 2.
29. Einollahi B, Alavian SM. Hepatitis C virus infection and kidney transplantation: a review for clinicians. Iran J Kidney Dis 2010; 4: 1-8.
30. UNAIDS. Aidsinfo country fact sheets: Iran. Available at: Http://www.Unaids.Org/en/dataanalysis/tools/aidsinfo/countryfactsheets/index.Html?Oas=oa2, oa1&country_id=asiirn (last accessed 23 June 2012).
31. Sharifi-Mood B, Alavi-Naini R, Salehi M, Hashemi M, Rakhshani F. Spectrum of clinical disease in a series of hospitalized HIV-infected patients from southeast of Iran. Saudi Med J 2006; 27: 1362-1366.
32. Khalili H, Rohani R, Seyedalinaghi S, Hajiabdolbaghi M, Dashti-Khavidaki S, Talasaz AH. Adherence to antiretroviral therapy among Iranian HIV/AIDS patients. Curr Clin Pharmacol 2012; 7: 111-115.
33. Rezaianzadeh A, Hasanzadeh J, Alipour A, Davarpanah MA, Rajaeifard A, Tabatabaee SH. Impact of hepatitis C on survival of HIV-infected individuals in Shiraz; south of Iran. Hepat Mon 2012; 12: 106-111.
34. SeyedAlinaghi S, Jam S, Mehrkhani F et al. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran. Acta Med Iran 2011; 49: 252-257.
35. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 1979; 15: 307-417.
36. Chinikar S, Ghiasi SM, Hewson R, Moradi M, Haeri A. Crimean-Congo hemorrhagic fever in Iran and neighboring countries. J Clin Virol 2010; 47: 110-114.
37. Izadi S, Holakouie-Naieni K, Majdzadeh SR et al. Seroprevalence of Crimean-Congo hemorrhagic fever in Sistan-va-baluchestan province of Iran. Jpn J Infect Dis 2006; 59: 326-328.
38. Chinikar S, Ghiasi SM, Moradi M et al. Geographical distribution and surveillance of Crimean-Congo hemorrhagic fever in Iran. Vector Borne Zoonotic Dis 2010; 10: 705-708.
39. Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg 2009; 81: 675-678.
40. Ahmadnejad F, Otarod V, Fallah MH et al. Spread of West Nile virus in Iran: a cross-sectional serosurvey in equines, 2008-2009. Epidemiol Infect 2011; 139: 1587-1593.
41. Sharifi Z, Mahmoodian Shooshtari M, Talebian A. A study of West Nile virus infection in Iranian blood donors. Arch Iran Med 2010; 13: 1-4.
42. Chinikar S, Javadi A, Ataei B et al. Detection of West Nile virus genome and specific antibodies in Iranian encephalitis patients. Epidemiol Infect 2012; 140: 1525-1529.
43. World Health Organization. Tuberculosis profile 2012. Available at: Https://extranet.Who.Int/sree/reports?Op=replet&name=/who_hq_reports/g2/prod/ext/tbcountryprofile&iso2=ir&outtype=html (last accessed 23 June 2012).
44. Velayati AA. Tuberculosis.. In: Azizi F, Janghorbani M, Hatami H, eds. Epidemiology and control of common disease in Iran, 3rd edn. Tehran: Shahid Beheshti University of Medical Sciences, 2010; 754-766. [In Persian.]
45. Merza MA, Farnia P, Tabarsi P, Khazampour M, Masjedi MR, Velayati AA. Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysis. J Infect Dev Ctries 2011; 5: 511-519.
46. Refai M. Incidence and control of brucellosis in the near east region. Vet Microbiol 2002; 90: 81-110.
47. Regional Animal Disease Surveillance and Control Network, Food and Agriculture Organization of the United Nations. A perspective of brucellosis surveillance in North Africa and Middle East. Available at: Http://www.Fao.Org/waicent/faoinfo/agricult/aga/agah/id/radiscon/brucactsurv.Pdf (last accessed 23 June 2012).
48. World Organisation for Animal Health. Handistatus ii: zoonoses (human cases): global cases of brucellosis in 2003. Available at: Http://www.Oie.Int/hs2/gi_zoon_mald.Asp?C_cont=6&c_mald=172&annee=2003 (last accessed 23 June 2012).
49. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006; 6: 91-99.
50. Beheshti S, Rezaian GR, Azad F, Faghiri Z, Taheri F. Seroprevalence of brucellosis and risk factors related to high risk occupational groups in Kazeroon, south of Iran. Int J Occup Environ Med 2010; 1: 62-68.
51. Alizadeh AH, Behrouz N, Salmanzadeh S et al. Escherichia coli, Shigella and Salmonella species in acute diarrhoea in Hamedan, Islamic Republic of Iran. East Mediterr Health J 2007; 13: 243-249.
52. Fard AH, Bokaeian M, Qureishi ME. Frequency of Escherichia coli O157:H7 in children with diarrhoea in Zahedan, Islamic Republic of Iran. East Mediterr Health J 2008; 14: 1022-1027.
53. Ghaemi EO, Aslani MM, Moradi AV et al. Epidemiology of Shigella-associated diarrhea in Gorgan, north of Iran. Saudi J Gastroenterol 2007; 13: 129-132.
54. Hassanzadeh P, Motamedifar M. Occurrence of Campylobacter jejuni in Shiraz, southwest Iran. Med Princ Pract 2007; 16: 59-62.
55. Pourshafie MR, Saifi M, Mousavi SF, Sedaghat M, Nikbakht GH, Rubino S. Clonal diversity of Salmonella enterica serotype typhi isolated from patients with typhoid fever in Tehran. Scand J Infect Dis 2008; 40: 18-23.
56. Tajbakhsh M, Hendriksen RS, Nochi Z, Zali MR, Aarestrup FM, Garcia-Migura L. Antimicrobial resistance in Salmonella spp. recovered from patients admitted to six different hospitals in Tehran, Iran from 2007 to 2008. Folia Microbiol (Praha) 2012; 57: 91-97.
57. Zali MR, Mirsattari D. Peptic ulcer disease. In: Azizi F, Janghorbani M, Hatami H, eds. Epidemiology and control of common disease in Iran, 3rd edn. Tehran: Shahid Beheshti University of Medical Sciences, 2010; 142-159. [In Persian.]
58. Ghazvini K, Ahmadnia H, Ghanaat J. Frequency of Chlamydia trachomatis among male patients with urethritis in northeast of Iran detected by polymerase chain reaction. Saudi J Kidney Dis Transpl 2012; 23: 316-320.
59. Hashemi FB, Pourakbari B, Yazdi JZ. Frequency of Chlamydia trachomatis in women with cervicitis in Tehran, Iran. Infect Dis Obstet Gynecol 2009; 2009: 67014.
60. Esmaeili R, Hesamzadeh A, Alizadeh-Navaei R, Haghshenas MH, Alhani F. Incidence of leptospirosis in Mazandaran province, north of Iran: a one year survey. Pak J Biol Sci 2009; 12: 1330-1333.
61. Brown PD, McKenzie M, Pinnock M, McGrowder D. Environmental risk factors associated with leptospirosis among butchers and their associates in Jamaica. Int J Occup Environ Med 2011; 2: 47-57.
62. Khalili M, Shahabi-Nejad N, Golchin M. Q fever serology in febrile patients in southeast Iran. Trans R Soc Trop Med Hyg 2010; 104: 623-624.
63. Fard SN, Khalili M. PCR-detection of Coxiella burnetii in ticks collected from sheep and goats in southeast Iran. Iran J Arthropod Borne Dis 2011; 5: 1-6.
64. Bashiribod H. Serological investigations for listeriosis antibodies in Iran. Geogr Med Suppl 1989; 5: 209-210.
65. Jamshidi M, Jahromi AS, Davoodian P, Amirian M, Zangeneh M, Jadcareh F. Seropositivity for Listeria monocytogenes in women with spontaneous abortion: a case-control study in Iran. Taiwan J Obstet Gynecol 2009; 48: 46-48.
66. Reza R. General survey of the present distribution of helminths in Iran and comparison with those of past years. Acta Trop 1976; 33: 177-184. [In French.]
67. Moshfea A, Sharifi A. Prevalence of intestinal parasites in primary school students of Yasuj. J Yasuj Univ Med Sci. 2001; 5: 1-9. [In Persian.]
68. Rokni MB. The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol 2008; 102: 283-295.
69. Hotez PJ, Savioli L, Fenwick A. Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis 2012; 6: e1475.
70. Sayyari AA, Imanzadeh F, Bagheri Yazdi SA, Karami H, Yaghoobi M. Prevalence of intestinal parasitic infections in the Islamic Republic of Iran. East Mediterr Health J 2005; 11: 377-383.
71. Hatami H. Giardiasis. In: Azizi F, Janghorbani M, Hatami H, eds. Epidemiology and control of common disease in Iran, 3rd edn. Tehran: Shahid Beheshti University of Medical Sciences, 2010; 528-533. [In Persian.]
72. Yadollahie M, Roshanipoor M, Motallebipoor SA, Habibzadeh F. Giardiasis in a 16-day-old neonate. East Mediterr Health J 2002; 8: 189-191.
73. Dalimi A, Motamedi G, Hosseini M et al. Echinococcosis/hydatidosis in western Iran. Vet Parasitol 2002; 105: 161-171.
74. Eslami A, Hosseini SH. Echinococcus granulosus infection of farm dogs of Iran. Parasitol Res 1998; 84: 205-207.
75. Moghaddam AS, Massoud J, Mahmoodi M et al. Human and animal fascioliasis in Mazandaran province, northern Iran. Parasitol Res 2004; 94: 61-69.
76. Hatami H, Asmar M, Massoud J et al. Report of the first outbreak of human fasciolosis in Kermanshah province. Moddares J 2000; 3: 79-87.
77. Yaghoobi R, Hoghooghi-Rad N. Mucosal leishmaniasis: report of three cases. Arch Iran Med 2001; 4: 138-140.
78. Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int J Antimicrob Agents 2010; 36 (suppl 1): S62-S65.
79. Habibzadeh F, Sajedianfard J, Yadollahie M. Isolated lingual leishmaniasis. J Postgrad Med 2005; 51: 218-219.
80. Ardehali S, Sadeghi-Hassanabadi A, Moaddeb A, Abdollahi B, Malek-Hosseini Z, Evans DA. The characterization of Leishmania from patients with lymphadenopathy in Shiraz, Iran. Trans R Soc Trop Med Hyg 1995; 89: 370-371.
81. Motazedian H, Noamanpoor B, Ardehali S. Characterization of Leishmania parasites isolated from provinces of the Islamic Republic of Iran. East Mediterr Health J 2002; 8: 338-344.
82. Habibzadeh F, Yadollahie M, Merat A, Haghshenas M. Thalassemia in Iran; an overview. Arch Iran Med 1998; 1: 27-33.
83. World Health Organization. World malaria report 2011. Available at: Http://www.Who.Int/malaria/publications/country-profiles/profile_irn_en.Pdf (last accessed 23 June 2012).
84. Raiesi A, Nikpour F, Ansari-Moghaddam A et al. Baseline results of the first malaria indicator survey in Iran at the health facility level. Malar J 2011; 10: 319.
85. World Health Organization. Regional health observatory: malaria, reported confirmed cases. Available at: Http://rho.Emro.Who.Int/rhodata/?Vid=2694 (last accessed 23 August 2012).
86. Askarian M, Gooran NR. National nosocomial infection surveillance system-based study in Iran: additional hospital stay attributable to nosocomial infections. Am J Infect Control 2003; 31: 465-468.
87. Masoumi Asl H. The national nosocomial infections surveillance in Iran: a 4 years report. BMC Proc 2011; 5 (suppl 6): P243.
88. Askarian M, Yadollahi M, Assadian O. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran. J Infect Public Health 2012; 5: 169-176.
89. Japoni A, Vazin A, Davarpanah MA et al. Ventilator-associated pneumonia in Iranian intensive care units. J Infect Dev Ctries 2011; 5: 286-293.
90. Nosrati M, Boroumand M, Tahmasebi S, Sotoudeh M, Sheikhfathollahi M, Goodarzynejad H. Excess costs associated with common healthcare-associated infections in an Iranian cardiac surgical unit. J Hosp Infect 2010; 76: 304-307.
91. Taher MT, Golestanpour A. Symptomatic nosocomial urinary tract infection in ICU patients: identification of antimicrobial resistance pattern. Iran J Clin Infect Dis 2009; 4: 25-29.
92. Habibzadeh F. Transplantation in the middle east. Lancet ME. 2012. Available at: Http://download.Thelancet.Com/flatcontentassets/pdfs/mar12_middleeasted_transplantation.Pdf?Elsca1=050312&elsca2=middleeadted&elsca3=segment (last accessed 23 June 2012).
93. Badiee P, Alborzi A. Invasive fungal infections in renal transplant recipients. Exp Clin Transplant 2011; 9: 355-362.
94. Ashtiani MT, Monajemzadeh M, Kashi L. Trends in antimicrobial resistance of fecal Shigella and Salmonella isolates in Tehran, Iran. Indian J Pathol Microbiol 2009; 52: 52-55.
95. Ansari F. Use of systemic anti-infective agents in Iran during 1997-1998. Eur J Clin Pharmacol 2001; 57: 547-551.
96. Habibzadeh F. Antibiotic misuse and antibiotic-resistant bacteria. Lancet ME. 2012.Available at: Http://download.Thelancet.Com/flatcontentassets/pdfs/mar12_middleeasted_transplantation.Pdf?Elsca1=050312&elsca2=middleeadted&elsca3=segment (last accessed 23 June 2012).
97. Pourakbari B, Sadr A, Ashtiani MT et al. Five-year evaluation of the antimicrobial susceptibility patterns of bacteria causing bloodstream infections in Iran. J Infect Dev Ctries 2012; 6: 120-125.
98. Peymani A, Nahaei MR, Farajnia S et al. High prevalence of metallo-beta-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn J Infect Dis 2011; 64: 69-71.
99. Khosravi AD, Mihani F. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Diagn Microbiol Infect Dis 2008; 60: 125-128.
100. Memish ZA, Stephens GM, Steffen R, Ahmed QA. Emergence of medicine for mass gatherings: lessons from the Hajj. Lancet Infect Dis 2012; 12: 56-65.